The successful application of NGS technologies to a problem of this scale and scope speaks to the power of innovation. Here are a few new NGS solutions for COVID-19 research applications.
The Zetasizer Advance family is the most versatile and flexible range of light scattering systems on the market, with a solution for every challenge and every budget.
By automating tasks and increasing precision, new liquid handling technologies serve to streamline workflows and free up the hands of researchers to focus on the important stuff – the science.
New products and technologies are helping to arm scientists and medical professionals – providing the insight needed in the fight against this unprecedented viral disease.
The world of microscopy has a rich and vivid history -- two very recent breakthroughs shine even greater light on an already brilliant field of view.
Research into SARS-CoV-2 spike protein and other areas are contributing to the development of viable vaccines, drugs, and therapeutic antibodies -- all benefiting from new glycan analysis and LC-MS solutions.
Understanding the strengths and limitations of real-time RT-PCR is essential for examining the current virus outbreak and for those that may emerge in the future.
Bold innovations in sample collection, point of care detection, immunity profiling and other applications are adding new firepower in the fight against COVID-19.
Companies have stepped forward with innovative products in the areas of personal protective equipment, testing and diagnostics, safety and automation, and others in the fight against the COVID-19 pandemic.
The Emerging Trends in Infectious Disease Interactive Infographic is a living resource -- this post serves as a chronology of the infographic, citing ongoing developments in the areas of: Detection and Containment, Diagnosis and Treatment, Laboratory Equipment, and Prevention and Surveillance.
The Virus Surface to a Novel COVID-19 Vaccine Candidate: The Journey of the SARS-CoV-2 Spike Protein
Intensive analysis of the spike protein led to the development of the first vaccine candidate approved for clinical trials. Perhaps overshadowed, is the unprecedented collaboration between academic scientists, government institutions, and private industry central to this remarkable work.
High-resolution cryo-electron microscopy imaging of the CoV spike protein complex has revealed both expected and novel structural elements – signifying capabilities previously not observed in this family of coronaviruses..
Challenges with the approval of COVID-19 test diagnostics uncovered serious process issues that are now being resolved in order to contain the current outbreak and to fight future pathogens.